| PCMA Comments in Response to AEOB GFE RFI - November 14 2022.pdf | |
| PCMA Comments on CMS Post-COVID RFI - Make Your Voice Heard - November 3, 2022.pdf | |
| PCMA Comments on 1557 Proposed Rule - October 3 2022.pdf | |
| PCMA Comments on AHRQ CED - September 28, 2022.pdf | |
| PCMA Comments on CY2023 Physician Fee Schedule - September 6 2022.pdf | |
| PCMA Comments on HHS Primary Care RFI - August 1, 2022.pdf | |
| PCMA comments on Section 204 - RxDC - CMS-10788 - July 28, 2022.pdf | |
| PCMA comments on OA REMS - June 21 2022.pdf | |
| PCMA comments on HIPAA HITECH RFI - June 6 2022.pdf | |
| PCMA comments on DHS Public Charge - April 25 2022.pdf | |
| PCMA response to ONC RFI on e-PA - March 24 2022.pdf | |
| PCMA Comments on CY2023 Policy and Technical Changes (CMS-4192-P) - March 7 2022.pdf | |
| PCMA comments on CY 2023 Advance Notice - March 4 2022.pdf | |
| PCMA comments on CMS-10141 CY2023 Model EOBs February 18 2022.pdf | |
| PCMA comments on proposed NCD for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease - February 10, 2022.pdf | |
| PCMA comments on 2023 Letter to Issuers in the Federally-facilitated Exchanges - January 27, 2022.pdf | |
| PCMA comments on CY2023 NBPP - January 27 2022.pdf | |
| PCMA comments on Prescription Drug and Healthcare Spending - January 24 2022.pdf | |
| PCMA comments on DEA Transfer of Electronic Prescriptions - January 18 2022.pdf | |
| PCMA comments on Regulation of Telepharmacy Practice - January 18 2022.pdf | |
| PCMA comments on CMS vaccination mandate IFR - January 4 2022.pdf | |
| PCMA Comments on CMS OTP Payment Freeze for Methadone - January 3 2022.pdf | |
